Lyra Therapeutics, Inc.LYRANASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank4
Year-over-Year Change
Year-over-year revenue growth rate
Percentile
P4
Near historical low
vs 2Y Ago
-4.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -86.34% |
| Q2 2025 | 0.00% |
| Q1 2025 | -12.44% |
| Q4 2024 | 7.18% |
| Q3 2024 | -67.39% |
| Q2 2024 | 12.41% |
| Q1 2024 | 264.38% |
| Q4 2023 | -73.16% |
| Q3 2023 | 18.78% |
| Q2 2023 | 11.71% |
| Q1 2023 | 3627.27% |
| Q4 2022 | -96.94% |
| Q3 2022 | -31.62% |
| Q2 2022 | 12.18% |
| Q1 2022 | 72.69% |
| Q4 2021 | 1835.71% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |